Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The study will last about 7 weeks and will include 10 back-to-back overnight stays in the research center.
Official title: An Open-Label, Randomized, 3-Way Crossover Study Comparing the Pharmacokinetics of Multiple Olomorasib (LY3537982) Capsules
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-07-11
Completion Date
2025-11
Last Updated
2025-10-20
Healthy Volunteers
Yes
Conditions
Interventions
Olomorasib
Single dose
Locations (2)
ICON Early Phase Services
San Antonio, Texas, United States
ICON
Salt Lake City, Utah, United States